Bri-Chem Corp.

As of June 30, 2026, Bri-Chem Corp. carries a market capitalization of 10.04M, placing it among publicly traded companies globally. Its enterprise value stands at 23.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Bri-Chem Corp. has 26.43M shares outstanding.

As of June 30, 2026, Bri-Chem Corp. trades at a trailing price-to-earnings ratio of 11.82. The price-to-sales ratio is 0.15, and the price-to-book ratio stands at 0.49.

As of June 30, 2026, Bri-Chem Corp. trades at an EV/EBITDA multiple of 6.79 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.35 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.64 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 23.71M versus a market cap of 10.04M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bri-Chem Corp. maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.21, indicating elevated leverage, while an interest coverage ratio of 1.63 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bri-Chem Corp. posted a return on equity (ROE) of 4.24, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 1.79, measuring how efficiently the asset base is converted into earnings. The company generates approximately 1.21M in revenue per employee across its workforce of 55.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.08 indicates how many times Bri-Chem Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bri-Chem Corp. recorded an income tax benefit of -362,179.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 487,372.00, leaving 849,551.00 in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 19, 2026, Bri-Chem Corp.'s stock has declined approximately 27.78% over the past 52 weeks. The 50-day moving average sits at 0.49, while the 200-day moving average is 0.26.

Over the twelve months ended June 30, 2026, Bri-Chem Corp. generated 67.23M in revenue and converted that into 849,551.00 in net income, yielding earnings per share of 0.03. EBITDA reached 3.49M, while operating income came in at 1.92M.

These figures are as of June 30, 2026. Total book value stands at 20.63M, with working capital of 5.42M providing operational flexibility.

Bri-Chem Corp. produced 8.42M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -380,332.00 in capital expenditures, free cash flow totaled 8.04M - equivalent to 0.30 per share.

Over the twelve months ended June 30, 2026, Bri-Chem Corp. posted a gross margin of 19.92, reflecting its pricing power and cost economics. The operating margin of 2.85 and net profit margin of 1.26 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bri-Chem Corp. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 79.12, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 80.08, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Bri-Chem Corp. shareholders.

Bri-Chem Corp.'s most recent stock split took place on January 11, 2007 with a 5:1 split ratio.

As of June 30, 2026, Bri-Chem Corp. has an Altman Z-Score of 1.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.